VLDL from Metabolic Syndrome Individuals Enhanced Lipid Accumulation in Atria with Association of Susceptibility to Atrial Fibrillation
Metabolic syndrome (MetS) represents a cluster of metabolic derangements. Dyslipidemia is an important factor in MetS and is related to atrial fibrillation (AF). We hypothesized that very low density lipoproteins (VLDL) in MetS (MetS-VLDL) may induce atrial dilatation and vulnerability to AF. VLDL w...
Main Authors: | Hsiang-Chun Lee, Hsin-Ting Lin, Liang-Yin Ke, Chi Wei, Yi-Lin Hsiao, Chih-Sheng Chu, Wen-Ter Lai, Shyi-Jang Shin, Chu-Huang Chen, Sheng-Hsiung Sheu, Bin-Nan Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/1/134 |
Similar Items
-
The Pathogenic Role of Very Low Density Lipoprotein on Atrial Remodeling in the Metabolic Syndrome
by: Hsiang-Chun Lee, et al.
Published: (2020-01-01) -
Very Low-Density Lipoproteins of Metabolic Syndrome Modulates STIM1, Suppresses Store-Operated Calcium Entry, and Deranges Myofilament Proteins in Atrial Myocytes
by: Yi-Lin Shiou, et al.
Published: (2019-06-01) -
The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome
by: Hsiang-Chun Lee, et al.
Published: (2020-09-01) -
The use of monocyte to HDL ratio to predict postoperative atrial fibrillation after aortocoronary bypass graft surgery
by: Ahmet İlker Tekkeşin, et al.
Published: (2017-08-01) -
The Role of Serum Lp (a) in Increasing the Risk of Thrombus Formation in Patients With Atrial Fibrillation
by: Ali Kazemi Saeed, et al.
Published: (2007-01-01)